ClinicalTrials.Veeva

Menu

Post Marketing Surveillance of MENOPUR

Ferring logo

Ferring

Status

Completed

Conditions

Infertility

Study type

Observational

Funder types

Industry

Identifiers

NCT01202123
FE999906 CS10

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of highly purified (HP) menotrophine to Korean women.

Enrollment

2,501 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Anovulation in women (WHO group II)
  • Controlled ovarian hyperstimulation cases for ART

Exclusion criteria

  • Hypersensitivity to MENOPUR
  • Pregnancy, lactation or contraindication to pregnancy
  • Ovarian cysts not related to polycystic ovarian syndrome
  • Abnormal uterine bleeding
  • Tumors in uterus, ovaries and breasts
  • Ovarian hyperstimulation syndrome
  • Thromboembolism or history of it
  • Infertile due to other reason than anovulation
  • High FSH level indication primary ovarian failure

Trial contacts and locations

19

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems